@gerryhanna : Enticing results reported in the TORCH study at #ASCO24 and just published in @JCO_ASCO 📢#Immunotherapy with chemotherapy (iTNT) in rectal cancer associated with complete response rates of 56.5% in group A and 54.2% in group B Full paper 🔗: ascopubs.org/doi/abs/150.120… • TwiCopy

Gerry Hanna

@gerryhanna

+ Follow

Radiation Oncologist at SLRON @stjamesdublin, Marie Curie Chair at @TCDRadTher and @CancerInstIRE wouldbe cyclist, sometimes pianist. Views are my own, RTs not

ID: 261294282

linkhttps://www.researchgate.net/profile/Gerard-Hanna calendar_today05-03-2011 17:18:54

12,12K Tweet

5,5K Followers

2,2K Following

Gerry Hanna

@gerryhanna

3 months ago

Enticing results reported in the TORCH study at #ASCO24 and just published in Journal of Clinical Oncology 📢#Immunotherapy with chemotherapy (iTNT) in rectal cancer associated with complete response rates of 56.5% in group A and 54.2% in group B Full paper 🔗: ascopubs.org/doi/abs/10.120…

Enticing results reported in the TORCH study at #ASCO24 and just published in <a href="/JCO_ASCO/">Journal of Clinical Oncology</a>

📢#Immunotherapy with chemotherapy (iTNT) in rectal cancer associated with complete response rates of 56.5% in group A and 54.2% in group B

Full paper 🔗: ascopubs.org/doi/abs/10.120…